Crossmark

Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study

Crossref DOI link: https://doi.org/10.1007/s12325-021-01970-w

Published Online: 2021-11-09

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dalén, Johan

Chitkara, Anushri

Svedbom, Axel

Olofsson, Tor

Puenpatom, Amy

Black, Christopher M.

Qureshi, Zaina P. https://orcid.org/0000-0001-9605-3980
License Information

Text and Data Mining valid from 2021-11-09

Version of Record valid from 2021-11-09
More Information

Article History

Received: 30 August 2021

Accepted: 18 October 2021

First Online: 9 November 2021

Change Date: 3 March 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s12325-022-02043-2

Updates are available Correction dated 2022-03-03

Click to view Correction: https://doi.org/10.1007/s12325-022-02043-2